Iodine-125 electrons from the radioisotope have been found in one study to do little cellular damage, unless the radionuclide is incorporated chemically directly into cellular DNA, which is not the case for present radiopharmaceuticals which use I-125 as the radioactive label nuclide. As with other radioisotopes of iodine, iodine-125 uptake in the body (mostly to the thyroid) can be blocked with prompt administration of stable iodine-127 in the form of an iodide or iodate salt. Potassium iodide (KI) is typically used for this purpose. Iodine-125 Iodine-125 (I) is a radioisotope of iodine which has uses in biological assays, nuclear medicine imaging
Lugol's iodine 126.5 mg/mL. The 15% solution thus has a total iodine content of 6.32 mg per drop of 0.05 mL; the 2% solution has 0.84 mg total iodine content per drop. Potassium iodide renders the elementary iodine soluble in water through the formation of the triiodide () ion. It is not to be confused with tincture of iodine solutions, which consist of elemental iodine, and iodide salts dissolved in water and alcohol. Lugol's solution contains no alcohol. Other names for Lugol's solution are (iodine-potassium iodide); Markodine, Strong solution (Systemic); and Aqueous Iodine Solution BP. In the United Kingdom the NHS pays